You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

phase retardation

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glaucoma Trial in Seoul (D565, D930)

Not yet recruiting
  • Glaucoma
  • Seoul, Korea, Republic of
    Seoul National University College of Medicine and Hospital
Jan 24, 2022

Uveal Melanoma Trial in Worldwide (LXS196, LXS196 and HDM201)

Terminated
  • Uveal Melanoma
  • New York, New York
  • +5 more
Sep 27, 2022

Hemoperfusion Efferon ?T for the Treatment of Acute Pancreatitis

Recruiting
  • Acute Pancreatitis With Uninfected Necrosis, Unspecified
  • Efferon CT
  • Moscow, Russian Federation
    N.V. Sklifosovsky Moscow Research Institute of Emergency
Jan 25, 2023

Pneumococcal Disease Trial in Worldwide (V116, PPSV23)

Recruiting
  • Pneumococcal Disease
  • V116
  • PPSV23
  • Blacktown, New South Wales, Australia
  • +50 more
Jan 25, 2023

Breast Tumors, Malignant Tumor of Breast Trial in Dallas (Trastuzumab, Ibrutinib 560 mg, Ibrutinib 840 mg)

Recruiting
  • Breast Neoplasms
  • Malignant Neoplasm of Breast
  • Dallas, Texas
    10 sites incl TX, WA, VA, and NV
May 16, 2022

End Stage Renal Disease, Haemodialysis, Diet, Healthy Trial in Ljubljana (medium cut-off (MCO) dialysis membrane, Dietary fiber

Recruiting
  • End Stage Renal Disease
  • +2 more
  • medium cut-off (MCO) dialysis membrane
  • +2 more
  • Ljubljana, Slovenia
    University Medical Center ljubljana
May 17, 2022

Bladder Cancer Trial in United States (Cabozantinib, Atezolizumab, Cystectomy)

Recruiting
  • Bladder Cancer
  • Hackensack, New Jersey
  • +4 more
Aug 26, 2022

Pharmacokinetics Trial in Burnaby (Quercetin LipoMicel (250 mg), Quercetin LipoMicel (500 mg), Quercetin LipoMicel (1000 mg))

Completed
  • Pharmacokinetics
  • Quercetin LipoMicel (250 mg)
  • +3 more
  • Burnaby, British Columbia, Canada
    ISURA
Nov 3, 2022

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

Recruiting
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +23 more
  • Quality-of-Life Assessment
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Nov 9, 2022

Recurrent Lung Squamous Cell Carcinoma, Stage IV Lung Squamous Cell Carcinoma AJCC v7 Trial in United States (Laboratory

Completed
Has Results
  • Recurrent Lung Squamous Cell Carcinoma
  • Stage IV Lung Squamous Cell Carcinoma AJCC v7
  • Laboratory Biomarker Analysis
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Mar 16, 2022

Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)

Not yet recruiting
  • Head and Neck Neoplasms
  • TransCon TLR7/8 Agonist
  • +2 more
  • (no location specified)
Aug 4, 2023

Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)

Recruiting
  • Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • +4 more
  • West Hollywood, California
  • +101 more
Jan 16, 2023

Leukemia, Myeloid, Acute Trial in United States (Liposomal Annamycin)

Completed
Has Results
  • Leukemia, Myeloid, Acute
  • Liposomal Annamycin
  • La Jolla, California
  • +3 more
Feb 28, 2022

CYP3A Inhibitor, Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma Trial in Heidelberg (Cobicistat Oral Tablet)

Not yet recruiting
  • CYP3A Inhibitor
  • Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma
  • Cobicistat Oral Tablet
  • Heidelberg, BW, Germany
    University Hospital Heidelberg
Aug 10, 2022

Obesity, Childhood Trial in Cincinnati (HALO, Enhanced Standard of Care)

Recruiting
  • Obesity, Childhood
  • HALO
  • Enhanced Standard of Care
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Jun 16, 2022

CNS Lymphoma, Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in San Francisco (Tafasitamab, Lenalidomide)

Recruiting
  • CNS Lymphoma
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Aug 10, 2022

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Evorpacept, Pembrolizumab)

Recruiting
  • Head and Neck Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Irvine, California
  • +10 more
Nov 4, 2021

Chordoma Trial in Baltimore, New York (other, biological, radiation)

Active, not recruiting
  • Chordoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Baltimore, Maryland
  • +1 more
Oct 3, 2022

Glioblastoma Trial in Köln, München, Münster (5-aminolevulinic acid)

Recruiting
  • Glioblastoma
  • 5-aminolevulinic acid
  • Köln, Germany
  • +2 more
Feb 2, 2022

Manualized MDMA-Assisted Therapy for Treatment of Posttraumatic

Enrolling by invitation
  • PTSD
    • San Francisco, California
      USCF
    Jan 23, 2023

    Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma, Advanced Gastric Carcinoma Trial in United States

    Recruiting
    • Advanced Colorectal Carcinoma
    • +42 more
    • Duarte, California
    • +9 more
    Jan 21, 2023

    Advanced Solid Tumor Trial (HLX23)

    Withdrawn
    • Advanced Solid Tumor
    • Los Angeles, California
    • +5 more
    Jan 13, 2023

    Renal Cell Cancer, Melanoma, Non-Small-Cell Lung Cancer Trial in Duarte, Louisville, New York (PF-07263689, Sasanlimab)

    Active, not recruiting
    • Renal Cell Cancer
    • +9 more
    • PF-07263689
    • Sasanlimab
    • Duarte, California
    • +5 more
    Nov 8, 2022

    COVID-19 Pneumonia, Tumors Malignant Trial in Jinan (EGCG, Placebo)

    Recruiting
    • COVID-19 Pneumonia
    • Neoplasms Malignant
    • Jinan, Shandong, China
      Shandong Cancer Hospital
    Mar 5, 2023

    HER2-PositiveRecurrent or Metastatic Breast Cancer Trial (SHR-A1811 Injection, SHR-A1811 Injection ; Pertuzumab Injection,

    Not yet recruiting
    • HER2-PositiveRecurrent or Metastatic Breast Cancer
    • SHR-A1811 Injection
    • +2 more
    • (no location specified)
    Sep 21, 2023